Paper Review Records
全部论文审稿周期
17 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
77
天
Novel 6-aryl-1-(3,4,5-trimethoxyphenyl)-1 H -pyrazolo[3,4-d]pyrimidine derivatives: design, synthesis, and biological evaluation as potent tubulin polymerisation inhibitors with anticancer activity
作者
Jiake Gao; Yujing Zhang; Rui Qu; Qianqian Xu; Zhenjuan Sun; Liya Cui; Chao Wang展开收起
作者单位
1. Department of Sports Medicine, The Affiliated Hospital of Qingdao University; 2. The Affiliated Cardiovascular Hospital of Qingdao University, Qingdao University; 3. Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University; 4. Health Management Center, Qingdao Women and Children’s Hospital, Qingdao University展开收起
63
天
Structure-based screening and identification of a novel Aurora-A-targeting peptide with antiproliferative activity against prostate cancer cells
作者
Bei-Bei Huang; Haijing Jiang; Yaozhi Hu; Jia-Jia Ge; Xiaohao Liu展开收起
作者单位
1. Drug Clinical Trial Facility Office, The Affiliated Hospital of Xuzhou Medical University; 2. Department of Pharmaceutical Analysis, China Pharmaceutical University展开收起
101
天
Design, synthesis, and stability evaluation of semaglutide-derived lactam-stapled peptide scaffolds for GLP-1R targeting
作者
Tingting Liu; Xintian Ren; Yanchen Li; Jin Wang; Jiaxin Chen; Roujia Lin; Jie Zhang展开收起
作者单位
1. School of Pharmacy, Health Science Center, Xi’an Jiaotong University展开收起
48
天
84
天
Context matters in PROTAC design: navigating the trade-off between degradation and developability
作者
Boxin Zhang; Yunfei Zhang; Bingxing Zhang; Jinrong Hu; Changhua Ke; Teng Wu; Meiyan Wei; Juan Xia; Mengzhou Wang; Qianqian Zhao; Lei Tian; Chengyuan Liang展开收起
作者单位
1. School of Biological and Pharmaceutical Sciences, Shaanxi University of Science & Technology; 2. Xi’an Key Laboratory for Antiviral and Antimicrobial-Resistant Bacteria Therapeutics Research; 3. Zhanjiang Institute of Clinical Medicine, Zhanjiang Central Hospital, Guangdong Medical University; 4. Xixian New Area Fenghou Original Medical Technology Co., Ltd展开收起
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
